Tang Capital Management LLC Elevation Oncology, Inc. Transaction History
Tang Capital Management LLC
- $1.17 Billion
- Q3 2024
A detailed history of Tang Capital Management LLC transactions in Elevation Oncology, Inc. stock. As of the latest transaction made, Tang Capital Management LLC holds 4,760,000 shares of ELEV stock, worth $3.38 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
4,760,000
Previous 3,060,000
55.56%
Holding current value
$3.38 Million
Previous $8.26 Million
65.43%
% of portfolio
0.24%
Previous 1.01%
Shares
6 transactions
Others Institutions Holding ELEV
# of Institutions
68Shares Held
45.4MCall Options Held
700Put Options Held
27.6K-
Frazier Life Sciences Management, L.P. Menlo Park, CA5.99MShares$4.26 Million0.19% of portfolio
-
Goldman Sachs Group Inc New York, NY3.99MShares$2.83 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.53MShares$2.5 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.07MShares$2.18 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.97MShares$2.11 Million0.06% of portfolio
About Elevation Oncology, Inc.
- Ticker ELEV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,300,900
- Market Cap $16.5M
- Description
- Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced sol...